Udo Jonas

14.1k total citations
391 papers, 10.3k citations indexed

About

Udo Jonas is a scholar working on Urology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Udo Jonas has authored 391 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Urology, 116 papers in Psychiatry and Mental health and 89 papers in Surgery. Recurrent topics in Udo Jonas's work include Urinary Bladder and Prostate Research (114 papers), Sexual function and dysfunction studies (108 papers) and Hormonal and reproductive studies (70 papers). Udo Jonas is often cited by papers focused on Urinary Bladder and Prostate Research (114 papers), Sexual function and dysfunction studies (108 papers) and Hormonal and reproductive studies (70 papers). Udo Jonas collaborates with scholars based in Germany, Netherlands and United States. Udo Jonas's co-authors include Christian G. Stief, Stefan Ückert, Michael C. Truß, K. Höfner, Armin Becker, Markus A. Kuczyk, S. Machtens, D. Schultheiss, Matthias Oelke and Steven Siegel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Udo Jonas

375 papers receiving 9.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Udo Jonas Germany 52 5.1k 3.1k 2.8k 2.3k 2.1k 391 10.3k
Patrizio Rigatti Italy 66 4.2k 0.8× 3.7k 1.2× 3.4k 1.2× 3.8k 1.7× 8.5k 3.9× 364 15.0k
Trinity J. Bivalacqua United States 57 3.1k 0.6× 738 0.2× 5.3k 1.9× 5.7k 2.5× 1.9k 0.9× 478 15.3k
Ian Eardley United Kingdom 48 2.4k 0.5× 827 0.3× 4.5k 1.6× 1.6k 0.7× 594 0.3× 206 7.8k
Allen D. Seftel United States 42 1.9k 0.4× 683 0.2× 3.8k 1.4× 1.3k 0.6× 911 0.4× 251 6.8k
Martha M. Faraday United States 25 1.7k 0.3× 1.2k 0.4× 981 0.4× 1.0k 0.4× 1.9k 0.9× 37 5.4k
John P. Mulhall United States 67 4.2k 0.8× 1.3k 0.4× 9.8k 3.5× 4.0k 1.8× 2.9k 1.4× 447 14.6k
U. Engelmann Germany 33 1.8k 0.4× 711 0.2× 1.8k 0.6× 1.5k 0.6× 679 0.3× 209 4.8k
Arnold Melman United States 46 2.3k 0.5× 557 0.2× 3.8k 1.4× 910 0.4× 553 0.3× 240 6.6k
Maarten Albersen Belgium 35 1.7k 0.3× 653 0.2× 2.2k 0.8× 1.7k 0.7× 725 0.3× 248 4.6k
Hong‐Jeng Yu Taiwan 41 1.3k 0.3× 867 0.3× 286 0.1× 1.1k 0.5× 1.6k 0.7× 240 7.2k

Countries citing papers authored by Udo Jonas

Since Specialization
Citations

This map shows the geographic impact of Udo Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Jonas more than expected).

Fields of papers citing papers by Udo Jonas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Jonas. The network helps show where Udo Jonas may publish in the future.

Co-authorship network of co-authors of Udo Jonas

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Jonas. A scholar is included among the top collaborators of Udo Jonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Jonas. Udo Jonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Höfner, K., Martin Burkart, Giris Jacob, & Udo Jonas. (2009). Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World Journal of Urology. 28(3). 353–357. 17 indexed citations
2.
Ückert, Stefan, et al.. (2008). Cyclic AMP- and cyclic GMP-binding protein kinases in the human vagina: Expression and co-localization with eNOS, VIP and PGP 9.5. The Journal of Sexual Medicine. 5. 72–72. 1 indexed citations
3.
Herrmann, Thomas, Thorsten Bach, Florian Imkamp, et al.. (2007). FlexGuardTM: a new laser insertion sheath: functional aspects in ureterorenoscopy (URS). World Journal of Urology. 25(3). 269–273. 5 indexed citations
4.
Höfner, K., Martin Burkart, Giris Jacob, & Udo Jonas. (2007). Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World Journal of Urology. 25(6). 627–633. 30 indexed citations
5.
Ückert, Stefan, et al.. (2007). Functional Responses of Isolated Human Seminal Vesicle Tissue to Selective Phosphodiesterase Inhibitors. Urology. 70(1). 185–189. 28 indexed citations
6.
Heesakkers, John, Philip E.V. van Kerrebroeck, Magdy Hassouna, et al.. (2007). Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. British Journal of Urology. 101(3). 325–329. 58 indexed citations
7.
Herrmann, Thomas, et al.. (2006). Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?. World Journal of Urology. 24(4). 389–396. 13 indexed citations
8.
Stief, Christian G., Stefan Ückert, & Udo Jonas. (2005). Strategies in the oral pharmacotherapy of male erectile dysfunction viewed from bench and bedside (Part I). The Journal of Men s Health and Gender. 2(1). 87–94. 5 indexed citations
9.
Bischoff, Erwin, et al.. (2002). Funktionelle in vitro-Effekte CAMP/CGMP-modulierender Pharmaka am humanen Detrusormuskel. Journal für Kardiologie (Krause & Pachernegg GmbH). 9(1). 9–15. 6 indexed citations
10.
Oelke, Matthias, et al.. (2002). Increase in detrusor wall thickness indicates bladder outlet obstruction (BOO) in men. World Journal of Urology. 19(6). 443–452. 122 indexed citations
11.
Schultheiss, D., Sandra Müller, Wido Nager, et al.. (2001). Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World Journal of Urology. 19(1). 46–50. 98 indexed citations
12.
Schultheiss, D., Norbert Schlote, Christian G. Stief, & Udo Jonas. (2000). Erectile Dysfunction and Anejaculation. European Urology. 37(2). 241–251. 2 indexed citations
13.
Thüroff, J.W., et al.. (1998). Medical treatment and medical side effects in urinary incontinence in the elderly. World Journal of Urology. 16(S1). S48–S61. 41 indexed citations
14.
Taher, Akmal, Markus Meyer, Christian G. Stief, Udo Jonas, & W. G. Forssmann. (1997). Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle. World Journal of Urology. 15(1). 32–35. 66 indexed citations
15.
Kuczyk, M.A., C. Bokemeyer, Geoffrey P. Kohn, et al.. (1997). Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer. British Journal of Urology. 80(1). 18–24. 32 indexed citations
16.
Kuczyk, M.A., Carsten Bokemeyer, Hans‐Joachim Schmoll, & Udo Jonas. (1995). The Prognostic Role of Alterations of the p53 Tumor Suppressor Gene in Superficial and Advanced Stage Bladder Cancer. Oncology Research and Treatment. 18(3). 202–210. 1 indexed citations
17.
Allhoff, E. P., et al.. (1993). Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study. World Journal of Urology. 11(4). 201–5. 4 indexed citations
18.
Truß, M., et al.. (1993). Single Potential Analysis ofCavernous Electrical Activity. European Urology. 24(3). 358–365. 21 indexed citations
19.
Stief, Christian G., et al.. (1991). Single potential analysis of cavernous electrical activity. Urological Research. 19(5). 277–280. 8 indexed citations
20.
Thüroff, Joachim W., Udo Jonas, & H. Heidler. (1980). Urodynamik : Diagnostik der Funktionsstörungen des unteren Harntraktes. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrizio Rigatti Breakdown of academic impact, for papers by Trinity J. Bivalacqua Breakdown of academic impact, for papers by Ian Eardley Breakdown of academic impact, for papers by Allen D. Seftel Breakdown of academic impact, for papers by Martha M. Faraday Breakdown of academic impact, for papers by John P. Mulhall Breakdown of academic impact, for papers by U. Engelmann Breakdown of academic impact, for papers by Arnold Melman Breakdown of academic impact, for papers by Maarten Albersen Breakdown of academic impact, for papers by Hong‐Jeng Yu
Rankless by CCL
2026